Arimidex 1 mg

Dragon Pharma Arimidex

Dragon Pharma Arimidex 1 mg, containing the active pharmaceutical ingredient Anastrozole, is a premium-grade, third-generation aromatase inhibitor (AI) that serves as an essential cornerstone of responsible anabolic steroid use. For athletes and bodybuilders utilizing testosterone or other aromatizable androgens, managing resultant estrogen levels is not optional—it is critical for achieving desired results, maintaining health, and preventing debilitating side effects. Anastrozole works with high specificity and potency by selectively and competitively inhibiting the aromatase enzyme, the biological catalyst responsible for converting androgens into estrogens. This action provides precise control over estrogenic activity, allowing users to harness the full anabolic power of their cycle while mitigating the risks of gynecomastia, severe water retention, and hypertension.

Manufactured under strict cGMP protocols in Dragon Pharma's European facilities, each 1 mg tablet delivers a consistently dosed, highly bioavailable form of Anastrozole. Its non-steroidal structure and selective action offer significant advantages over older anti-estrogens, with a superior side-effect profile regarding liver toxicity. By effectively lowering circulating estradiol levels, Arimidex enables athletes to maintain a drier, harder, and more vascular physique throughout their cycle, directly countering the bloated, smooth look caused by estrogen-mediated water retention. Furthermore, its preventative use is the most effective strategy to avoid the development of gynecomastia, a condition that often requires surgical intervention if allowed to progress.

IMPORTANT PHARMACOLOGICAL NOTE: Anastrozole is a powerful endocrine agent. The goal of its use in a performance context is estrogen management, not eradication. Estrogen plays vital roles in libido, joint health, cardiovascular function, and cholesterol metabolism. Crashing estrogen levels through excessive dosing leads to severe side effects including joint pain, low libido, depression, and detrimental lipid profiles. Responsible use is characterized by a "lowest effective dose" approach—starting with 0.5 mg every other day or twice weekly—and ideally, is guided by periodic blood work to monitor estradiol levels within an optimal range (typically 20-30 pg/mL).

Key Benefits:

• Prevents & Reverses Gynecomastia: The most effective pharmaceutical defense against the development of estrogen-sensitive breast tissue in males, acting at the enzymatic source of excess estrogen.
• Eliminates Estrogenic Water Retention: Dramatically reduces subcutaneous water bloat, leading to a harder, more defined, and vascular muscle appearance, enhancing muscle separation and striations.
• Manages Blood Pressure & Reduces Cycle Strain: By mitigating fluid retention, it helps control cycle-induced hypertension and reduces overall cardiovascular stress associated with high estrogen.
• Non-Steroidal & Liver-Safe: As a non-steroidal aromatase inhibitor, it does not exert androgenic activity and is not associated with hepatotoxicity, making it safer for long-term management compared to some prohormones.
• Enhances the Efficacy of Aromatizing Cycles: Allows for the use of higher doses of potent aromatizing compounds like Sustanon 270 or Dianabol by keeping their estrogenic side effects in check, maximizing the net anabolic benefit.

Each sachet contains 100 tablets of 1mg Anastrozole, manufactured under strict quality control standards in Dragon Pharma's certified facilities.

Product Specifications

Usage Guidelines

Core Principle: Always use the lowest effective dose. Arimidex is powerful; more is not better. Estrogen is essential for health. Start low, assess tolerance and symptoms (or better yet, blood work), and adjust gradually.

• On-Cycle Prevention (Moderate Aromatizing Cycles): For cycles containing moderate doses of testosterone (e.g., 300-500 mg/week) or compounds like Deca 300, a standard starting protocol is 0.5 mg (half a tablet) every other day. Take your first dose 24-48 hours after your first testosterone injection. Monitor for signs of high estrogen (bloat, nipple sensitivity) or low estrogen (dry joints, low mood). Adjust frequency to 0.5 mg every 3rd day if side signs of low E2 appear.
• On-Cycle Management (Heavy Aromatizing Cycles): For aggressive cycles with compounds like Trenbolone (which can cause prolactin issues) or very high testosterone doses, estrogen control is paramount. A starting dose of 0.5 mg every day may be necessary but should be approached cautiously. Due to Tren's unique mechanism, having a dopamine agonist like Caber on hand is also advised. Blood work mid-cycle is highly recommended to fine-tune the Arimidex dose and avoid crashing estrogen.
• Post Cycle Therapy (PCT) Support (Short-Term): Arimidex is not a primary PCT drug. However, when coming off a heavy cycle, a surge in estrogen (rebound) can occur as Testosterone drops but aromatase activity remains. To mitigate this, some protocols include Arimidex at 0.5 mg every other day for the first 10-14 days of PCT only, alongside your primary SERMs like Clomid or Nolvadex. Do not run Arimidex throughout the entire PCT.

Side Effect Management & Important Notes:

If you experience symptoms of low estrogen (achy joints, dry skin, low libido, depression), immediately reduce your Arimidex dose or frequency. These symptoms indicate you have suppressed estrogen too far. Allow 5-7 days for levels to rebound after lowering the dose. For joint support if needed, consider supplements like fish oil or peptides such as BPC-157.

Liver & Cardiovascular Health:

While Anastrozole is not hepatotoxic, it can negatively impact cholesterol by lowering HDL (the "good" cholesterol). This is a significant reason to avoid excessive doses. Support your lipid profile with a heart-healthy diet, omega-3 fatty acids, and regular cardio. Avoid combining with other compounds that are harsh on lipids if possible. Regular blood work monitoring lipid panels is prudent for any user incorporating an AI long-term.

Third-Party Lab Tested

2025-09-02

View Result

1.05 mg

2024-06-17

View Result

1.19 mg

Note: Independent third-party lab testing consistently verifies the potency of Dragon Pharma Arimidex. The September 2025 result of 1.05 mg and the June 2024 result of 1.19 mg per tablet confirm the product's reliability and slight overdosing, ensuring you receive a consistently effective aromatase inhibitor for precise estrogen control.

Storage Instructions

Proper storage ensures the chemical stability and long-term efficacy of Anastrozole tablets.

• Environment: Store in a cool, dry place away from direct light and moisture. A medicine cabinet or drawer is ideal.
• Temperature: Maintain at room temperature between 20°C and 25°C (68°F and 77°F). Avoid freezing or storage in excessively hot environments.
• Container: Keep tablets in their original, sealed Dragon Pharma foil sachet until use. This protects the medication from air, light, and humidity.
• Safety: Store in a secure location out of the reach of children and pets. Keep away from women who are or could become pregnant.
• Shelf Life: When stored correctly, the product will retain its full potency for up to 3 years from the manufacturing date. Do not use if the packaging is damaged.